These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23209707)

  • 1. Human anti-Aβ IgGs target conformational epitopes on synthetic dimer assemblies and the AD brain-derived peptide.
    Welzel AT; Williams AD; McWilliams-Koeppen HP; Acero L; Weber A; Blinder V; Mably A; Bunk S; Hermann C; Farrell MA; Ehrlich HJ; Schwarz HP; Walsh DM; Solomon A; O'Nuallain B
    PLoS One; 2012; 7(11):e50317. PubMed ID: 23209707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.
    O'Nuallain B; Freir DB; Nicoll AJ; Risse E; Ferguson N; Herron CE; Collinge J; Walsh DM
    J Neurosci; 2010 Oct; 30(43):14411-9. PubMed ID: 20980598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain-derived synaptic plasticity-disrupting Aβ.
    O'Nuallain B; Klyubin I; Mc Donald JM; Foster JS; Welzel A; Barry A; Dykoski RK; Cleary JP; Gebbink MF; Rowan MJ; Walsh DM
    J Neurochem; 2011 Oct; 119(1):189-201. PubMed ID: 21781116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    Colvin BA; Rogers VA; Kulas JA; Ridgway EA; Amtashar FS; Combs CK; Nichols MR
    J Neurochem; 2017 Dec; 143(6):736-749. PubMed ID: 28881033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.
    Nichols MR; Moss MA; Reed DK; Cratic-McDaniel S; Hoh JH; Rosenberry TL
    J Biol Chem; 2005 Jan; 280(4):2471-80. PubMed ID: 15528204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic dimeric Aβ(28-40) mimics the complex epitope of human anti-Aβ autoantibodies against toxic Aβ oligomers.
    Roeder AM; Roettger Y; Stündel A; Dodel R; Geyer A
    J Biol Chem; 2013 Sep; 288(38):27638-27645. PubMed ID: 23846683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human plasma contains cross-reactive Abeta conformer-specific IgG antibodies.
    O'Nuallain B; Acero L; Williams AD; Koeppen HP; Weber A; Schwarz HP; Wall JS; Weiss DT; Solomon A
    Biochemistry; 2008 Nov; 47(47):12254-6. PubMed ID: 18956886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers.
    Ladiwala AR; Lin JC; Bale SS; Marcelino-Cruz AM; Bhattacharya M; Dordick JS; Tessier PM
    J Biol Chem; 2010 Jul; 285(31):24228-37. PubMed ID: 20511235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
    Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
    Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles.
    Rangachari V; Reed DK; Moore BD; Rosenberry TL
    Biochemistry; 2006 Jul; 45(28):8639-48. PubMed ID: 16834338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
    Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
    Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a single-chain variable fragment recognizing a linear epitope of aβ: a biotechnical tool for studies on Alzheimer's disease?
    Dornieden S; Müller-Schiffmann A; Sticht H; Jiang N; Cinar Y; Wördehoff M; Korth C; Funke SA; Willbold D
    PLoS One; 2013; 8(3):e59820. PubMed ID: 23555792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific.
    Zago W; Buttini M; Comery TA; Nishioka C; Gardai SJ; Seubert P; Games D; Bard F; Schenk D; Kinney GG
    J Neurosci; 2012 Feb; 32(8):2696-702. PubMed ID: 22357853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species.
    Ferrão-Gonzales AD; Robbs BK; Moreau VH; Ferreira A; Juliano L; Valente AP; Almeida FC; Silva JL; Foguel D
    J Biol Chem; 2005 Oct; 280(41):34747-54. PubMed ID: 16041062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of Abeta-related peptide--monoclonal antibody complexes.
    Gardberg A; Dice L; Pridgen K; Ko J; Patterson P; Ou S; Wetzel R; Dealwis C
    Biochemistry; 2009 Jun; 48(23):5210-7. PubMed ID: 19385664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between Soluble Species of β-Amyloid and α-Synuclein Promote Oligomerization while Inhibiting Fibrillization.
    Candreva J; Chau E; Rice ME; Kim JR
    Biochemistry; 2020 Feb; 59(4):425-435. PubMed ID: 31854188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies that target pathological assemblies of Abeta.
    Lambert MP; Velasco PT; Chang L; Viola KL; Fernandez S; Lacor PN; Khuon D; Gong Y; Bigio EH; Shaw P; De Felice FG; Krafft GA; Klein WL
    J Neurochem; 2007 Jan; 100(1):23-35. PubMed ID: 17116235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
    Britschgi M; Olin CE; Johns HT; Takeda-Uchimura Y; LeMieux MC; Rufibach K; Rajadas J; Zhang H; Tomooka B; Robinson WH; Clark CM; Fagan AM; Galasko DR; Holtzman DM; Jutel M; Kaye JA; Lemere CA; Leszek J; Li G; Peskind ER; Quinn JF; Yesavage JA; Ghiso JA; Wyss-Coray T
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12145-50. PubMed ID: 19581601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-amyloidogenic activity of IgGs contained in normal plasma.
    O'Nuallain B; Williams AD; McWilliams-Koeppen HP; Acero L; Weber A; Ehrlich H; Schwarz HP; Solomon A
    J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S37-42. PubMed ID: 20405179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of conformation- and sequence-specific antibodies against amyloid β.
    Perchiacca JM; Ladiwala AR; Bhattacharya M; Tessier PM
    Proc Natl Acad Sci U S A; 2012 Jan; 109(1):84-9. PubMed ID: 22171009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.